Sat.Nov 06, 2021 - Fri.Nov 12, 2021

article thumbnail

AI tool may help doctors select best drugs for COVID patients

pharmaphorum

Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients. The MOATAI-VIR algorithm, developed by scientists at Emory University and Georgia Tech, was put through its paces in a study that showed it was able to predict 24 out of 26 clinical manifestations of COVID-19, including acute respiratory distress, blood clotting issues, cytokine storms, brain fog, and loss of sm

article thumbnail

10 rural states launch lawsuit against CMS' COVID-19 vaccine mandate for healthcare workers

Fierce Healthcare

10 rural states launch lawsuit against CMS' COVID-19 vaccine mandate for healthcare workers. dmuoio. Thu, 11/11/2021 - 12:57.

Vaccines 142
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Variable-dose pen injector platform designed for simple use

Outsourcing Pharma

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

98
article thumbnail

Ep.015 – RJ Lewis and David Hunt, CEO of The Considered: Breaking the Rules in Pharma Advertising – November 3, 2021

Pharma Marketing Network

November 3, 2021 – Tune in with the Pharma Marketing Network for an exciting conversation with R.J. Lewis and David Hunt, CEO of The Considered, as he shares how his new independent agency, The Considered, about how they are breaking the rules in pharma advertising. David discusses and answers questions around: How The Considered is different. What launched the conception of the agency?

72
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

UK sets aside £248m to “digitise” NHS diagnostics

pharmaphorum

The UK government has announced £248 million in spending over the next year for a project to make it easier for patient test results and scans to be shared between hospitals, labs and GP surgeries. The aim is to “digitise diagnostics care” across the NHS, reducing the time it takes to diagnose health problems and get treatment started earlier, helping to address the massive backlog in care caused by the pandemic, according to a Department of Health and Social Care (DHSC) statement.

Hospitals 111
article thumbnail

Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm

Fierce Healthcare

Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm. pminemyer. Fri, 11/12/2021 - 18:06.

132
132

More Trending

article thumbnail

Build Back Better Act and 340B Impact

Turnkey Pharmacy Solutions

By Rob Nahoopii If you are like me, it feels like I have been on a roller coaster ride as I watch what is and what is not going to be included in the Social Reform Bill titled “Build Back Better Act” (BBBA) or H.R. 5376. I have also been having a hard time tracking.

52
article thumbnail

Scotland is world’s first country to greenlight Tagrisso for NSCLC

pharmaphorum

Scotland has given the green light to AstraZeneca’s Tagrisso for restricted use to treat adult patients with non-small cell lung cancer (NSCLC), making it the first country in the world to approve the routine use of the therapy in this setting. The Scottish Medicines Consortium (SMC) has approved Tagrisso (osimertinib) for use within NHS Scotland as a monotherapy for adjuvant treatment after tumour removal in adult patients with stage IB-IIIA NSCLC whose tumours have epidermal growth factor (EGF

article thumbnail

Industry Voices—Why primary care is the future of sustainable healthcare in the U.S.

Fierce Healthcare

Industry Voices—Why primary care is the future of sustainable healthcare in the U.S. hlandi. Sat, 11/06/2021 - 21:45.

141
141
article thumbnail

Sanofi, Be the Match, and DiMe to weigh in on patient centricity

Outsourcing Pharma

During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.

96
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pharma confidence surges as CPhI Worldwide 2021 opens

Pharma Mirror

Milan, CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 November, 2021) – opens its doors to international pharma for the first time in two years asindustry confidence surges to record highs according to executives in the CPhI Annual Survey. The survey insights are published as part of the CPhI Annual Report – which is launched each year at CPhI Worldwide – and compile the thoughts of over 370 executives from more than 30 countries.

52
article thumbnail

One world, one health: The interconnected web of antimicrobial resistance

pharmaphorum

Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and environmental drivers, consequences, and data. AMR threatens to undermine “almost a century of health gains” and marshalling a response to such a problem “requires cooperation at many levels”. That’s according to a newly published report from the US National Academies of Sciences, Engineering, and Medicine, which calls for a One Health approach that recognises the scale of th

article thumbnail

How this telehealth startup aims to address mental illness with ketamine therapy

Fierce Healthcare

How this telehealth startup aims to address mental illness with ketamine therapy. agliadkovskaya. Mon, 11/08/2021 - 13:17.

138
138
article thumbnail

Clinical Ink snaps up digital CNS research technology firm

Outsourcing Pharma

The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.

72
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025

Pharma Mirror

Milan, Ahead of the world’s largest pharma event – CPhI Worldwide taking place in Milan, Italy (9-11 November, 2021) – the third part of the CPhI Annual Report is released with key findings for biologics manufacturing, biotechs and CDMOs. CPhI experts – Dawn Ecker, Managing Director of bioTRAK Database Services at BDO and Fiona Barry, Editor at GlobalData PharmSource – look ahead to 2025 to predict the future demand for biologicals by volume, as well as the total capacity available and, the cons

52
article thumbnail

Valneva gets EU deal for COVID jab, and may sue UK

pharmaphorum

Shares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two years, including 27 million next year. The deal for the adjuvanted, inactivated SARS-CoV-2 vaccine still depends on authorisation of the jab by the European Medicines Agency (EMA) which is due to start a rolling review of VLA2001 shortly, but Valneva thinks it could start delivering supplies to the EU in April next year.

Vaccines 105
article thumbnail

Report ranks 10 most cost-efficient hospitals in the U.S., identifies $8B in potential Medicare savings

Fierce Healthcare

Report ranks 10 most cost-efficient hospitals in the U.S., identifies $8B in potential Medicare savings. agliadkovskaya. Mon, 11/08/2021 - 18:03.

Hospitals 126
article thumbnail

Use of robotics in pharma packaging, manufacturing on the rise: Beroe

Outsourcing Pharma

According to the market intelligence firm, automation appeals to drug packaging and manufacturing firms, thanks to their productivity-boosting potential.

article thumbnail

Antidepressant and Psychedelic Drug Interactions

The Spirit Pharmacist

Antidepressant and Psychedelic Interactions. The most common situations and clinical scenarios I consult about have to do with persons taking antidepressants that are interested in psychedelic therapies or have tried them while taking antidepressants with lackluster results. It’s truly a conundrum for serotonergic psychedelics as to how persons can best approach this work when the toughest part of it all may be weaning existing medications and getting the psychedelics to be potent and ther

52
article thumbnail

Moderna squares off with US government over COVID jab patent

pharmaphorum

After being hailed as a triumph of public-private drug development, Moderna’s partnership with the US government on its COVID-19 vaccine looks like it may descend into acrimony. That is according to a New York Times report , which says Moderna is now in dispute with the National Institutes of Health (NIH) after it filed a US patent in the US that claims the company’s scientists invented the vaccine on their own.

Vaccines 105
article thumbnail

Healthcare industry will face higher medication errors, declining patient trust in 2022: Forrester

Fierce Healthcare

Healthcare industry will face higher medication errors, declining patient trust in 2022: Forrester. agliadkovskaya. Tue, 11/09/2021 - 19:23.

124
124
article thumbnail

Pharmaceutical packaging firm adds QC laboratory in Ireland

Outsourcing Pharma

Wasdell, a UK-based packaging and manufacturing provider in the UK, has opened a quality control laboratory in Dundalk to analyze products for its pharmaceutical clientele.

article thumbnail

University of Oxford begins human trials of Ebola vaccine

Pharma Times

ChAdOxl biEBOV is being tested for safety and immunogenicity, and may protect against multiple species of the virus

article thumbnail

Germany says only Pfizer COVID jab should be used in under 30s

pharmaphorum

Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine Comirnaty, saying it seems less likely to cause heart inflammation than Moderna’s rival shot Spikevax. The draft guidance from the Robert Koch Institute’s STIKO committee also says that pregnant women, regardless of their age, should get the Pfizer/BioNTech vaccine.

Vaccines 104
article thumbnail

Nearly 60% of health systems aim to become 'payviders' in 2022, survey finds

Fierce Healthcare

Nearly 60% of health systems aim to become 'payviders' in 2022, survey finds. rking. Tue, 11/09/2021 - 13:51.

138
138
article thumbnail

Pharmaceutical industry confidence on the rise: CPhI Worldwide

Outsourcing Pharma

At the open of the global pharmaceutical industry gathering, a survey of executives from around the globe indicates a rosy mood among professionals in the field.

52
article thumbnail

Chemotherapy-Induced Nausea and Vomiting Update

Med Ed 101

Chemotherapy-induced nausea and vomiting (CINV) is one of the most common side effects in patients getting treated for cancer. Prevention for CINV is important to improve quality of life and treatment outcomes. Acute CINV is from the chemotherapeutic agents producing free radicals that stimulate GI release of serotonin. The serotonin binds to 5-HT3 receptors in […].

article thumbnail

COVID antibodies from Roche, Celltrion backed for approval in EU

pharmaphorum

The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, the first antibody-based therapies for coronavirus to be backed for full approval in the EU. Ronapreve (casirivimab and imdevimab) – developed and distributed by Regeneron as REGN-COV in the US – has been recommended by the CHMP for the treatment and prevention of COVID-19 in people aged 12 years and older weighing at least 40kg.

98
article thumbnail

Infrastructure bill includes record increase of 4,000 Medicare-supported GME slots to combat looming shortage

Fierce Healthcare

Infrastructure bill includes record increase of 4,000 Medicare-supported GME slots to combat looming shortage. rking. Tue, 11/09/2021 - 15:13.

122
122
article thumbnail

Industry veteran commits to improved patient solutions at CTMA

Outsourcing Pharma

After 30 yearsâ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.

52
article thumbnail

Azathioprine Clinical Pearls

Med Ed 101

Azathioprine isn’t a drug I see terribly often in clinical practice, but there are some really important things to remember. I recently put together a podcast on azathioprine and I wanted to share some of my top azathioprine clinical pearls with you. Azathioprine Clinical Pearls – Monitoring Parameters Azathioprine can cause a significant number of […].

40
article thumbnail

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

pharmaphorum

KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. [Image: From left, FIDE Directors Richard GB Langley, MD; Richard Warren, MD, PhD; Kenneth B Gordon, MD; Bruce E Strober, MD, PhD]. November 10, 2021, UK. Fishawack Health, the leading commercialization partner for the life science industry, welcomes FIDE to its group—an independent expert-led consultancy specia

article thumbnail

Express Scripts launches option for employers to cover over-the-counter COVID-19 tests

Fierce Healthcare

Express Scripts launches option for employers to cover over-the-counter COVID-19 tests. pminemyer. Wed, 11/10/2021 - 16:05.

130
130
article thumbnail

Neopac recyclable barrier tubes land sustainability award

Outsourcing Pharma

Polyfoil MMB mono-material tubes, designed to be recyclable, landed top honors in the Excellence in Sustainability at the recent Pharmapack Awards program.

52